Bay Street News, July 22nd, 2024

Amoytop to sponsor a Phase 1b exploratory clinical study evaluating the efficacy and safety of ALG-000184 in combination with PEGBING® […]

CARLSBAD, Calif., July 22, 2024 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release […]

Earnings Release: Monday, July 29, 2024, After Market Closes Conference Call and Webcast: Tuesday, July 30, 2024, at 10:00 A.M. […]

Partnership Anticipated to Drive Significant Revenue A.A. Milne’s Classic Books Gave Rise To $80 Billion in Retail Sales with Millions […]

SANTA MONICA, Calif., July 22, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and developers […]

Toronto, Ontario and Nucla, Colorado, July 22, 2024 (GLOBE NEWSWIRE) — Western Uranium & Vanadium Corp. (CSE: WUC) (OTCQX: WSTRF) […]

MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, […]

CAMBRIDGE, Mass., July 22, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine […]

SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) today announced that the […]

SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a […]